Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

AXSMAXSM
Showing 8 of 16 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in AXSOME THERAPEUTICS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of AXSM (AXSOME THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$359,480

Total Shares Change

-4,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$244.77
0
2026-Q1
Unchanged
4,000
0.0%
$676,0800.0%$164.05
0
2025-Q4
Unchanged
4,000
0.0%
$730,5600.0%$148.79
0
2025-Q3
Unchanged
4,000
0.0%
$485,8000.0%$117.62
0
2025-Q2
Unchanged
4,000
0.0%
$417,5600.0%$103.36
0
2025-Q1
Unchanged
4,000
0.0%
$466,5200.0%$118.53
0
2024-Q4
Unchanged
4,000
0.0%
$338,4400.0%$84.78
0
2024-Q3
Unchanged
4,000
0.0%
$359,4800.0%$89.64
0

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used